Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Twist Bioscience Corporation - Common Stock (NQ:TWST)

181.38 -1.46 (-0.80%)
Streaming Delayed Price Updated: 10:26 AM EDT, Sep 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Twist Bioscience Corporation - Common Stock

< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Gainers 
Via Benzinga
News headline image
Twist Bioscience Highlights Synthetic Libraries and High Throughput Antibody Discovery Platform at PEGS Boston 2022
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Launches High Throughput Antibody Production Platform
From Twist Bioscience Corporation
Via Business Wire
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low. 
Via Benzinga
News headline image
Twist Bioscience Clocks ~50% Jump In Q1 Sales, Lifts FY22 Revenue Guidance ↗
Twist Bioscience Corp (NASDAQ: TWST) reported a  
Via Benzinga
News headline image
Recap: Twist Bioscience Q1 Earnings ↗
  Twist Bioscience (NASDAQ:TWST) reported its Q1 earnings results on Friday, February 4, 2022 at 07:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
On Thursday, 236 companies hit new 52-week lows. 
Via Benzinga
News headline image
Twist Bioscience to Become Voting Member of Storage Networking Industry Association
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Announces Promotions and Changes to Executive Leadership Team
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Report Fiscal 2022 Second Quarter Financial Results on Thursday, May 5, 2022
From Twist Bioscience Corporation
Via Business Wire
News headline image
Baillie Gifford Just Bought Ginkgo Bioworks (DNA) Stock. Here’s Why. ↗
Baillie Gifford recently disclosed that it purchased 48.8 million shares of DNA stock on March 31. The firm has a $180 billion portfolio. 
Via InvestorPlace
News headline image
Twist Bioscience Inks Antibody Discovery Pact With MediSix Therapeutics ↗
Twist Bioscience Corporation (NASDAQ: TWST) and MediSix Therapeutics have collaborated to discover novel antibodies  
Via Benzinga
News headline image
Twist Bioscience Signs Antibody Discovery Collaboration with MediSix Therapeutics to Develop T-cell Therapies
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience and Ginkgo Bioworks Sign New Collaboration
From Twist Bioscience Corporation
Via Business Wire
News headline image
DNA Data Storage Alliance Welcomes 50th Member
From DNA Data Storage Alliance
Via Business Wire
News headline image
Know The 2 Healthcare Companies Cathie Wood's Ark Invest Bought On Friday ↗
Cathie Wood's Ark Invest may have had a disappointing 2021, but the fund's purchases/liquidations are always watched keenly by investors. On Friday, ETFs managed by... 
Via Benzinga
News headline image
Twist Bioscience Launches Synthetic RNA Positive Controls For SARS-CoV-2 Encapsulated Minicapsules ↗
Twist Bioscience Corporation (NASDAQ: TWST) has launched specific synthetic RNA positive controls for SARS-CoV-2 encapsulated in stainless steel mini capsules that... 
Via Benzinga
News headline image
Twist Bioscience Launches Synthetic RNA Positive Controls for SARS-CoV-2 Encapsulated in Imagene’s Stainless Steel Capsules
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Becomes Digital Preservation Coalition Supporter
From Twist Bioscience Corporation
Via Business Wire
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
Tuesday's session saw 729 companies set new 52-week lows. Areas of Interest About Today's 52-Week Lows: Amazon.com (NASDAQ:AMZN) was the largest firm on a... 
Via Benzinga
News headline image
Twist Bioscience to Present at Upcoming Virtual Conferences
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Raises $250M Via Equity Issued At 11% Discount ↗
Twist Bioscience Corporation (NASDAQ: TWST) has priced its upsized underwritten public offering of 4.5 million at $55.00 per share, with gross proceeds of approximately... 
Via Benzinga
News headline image
Twist Bioscience Announces Pricing of an Upsized $250 Million Public Offering of Common Stock
From Twist Bioscience Corporation
Via Business Wire
News headline image
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
Twist Bioscience to Participate in the 11th Annual SVB Leerink Global Healthcare Conference
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Announces Proposed Public Offering of Common Stock
From Twist Bioscience Corporation
Via Business Wire
News headline image
C2i Genomics Partners with Twist Bioscience to Launch Reference Materials for Whole-Genome Cancer Detection
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience, Eleven Therapeutics Create Synthetic Viral RNA Molecules To Develop Antiviral Vaccines, Therapeutics ↗
Twist Bioscience Corp (NASDAQ: TWST) and Eleven Therapeutics have created a replicon tool that could be used for studying viral genome replication, antiviral drug... 
Via Benzinga
News headline image
Twist Bioscience and Eleven Therapeutics Create Replicon for Development of Antiviral Tools
From Twist Bioscience Corporation
Via Business Wire
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.